UniProtKB/SwissProt variant VAR

Variant information

Variant position:

106

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Leucine (L) to Serine (S) at position 106 (L106S, p.Leu106Ser).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from medium size and hydrophobic (L) to small size and polar (S)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-2

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In FRDA.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs104894105 [ dbSNP | Ensembl ]

Sequence information

Variant position:

106

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

210

The length of the canonical sequence.

Location on the sequence:

HPGSLDETTYERLAEETLDS L AEFFEDLADKPYTFEDYDVS

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         HPGSLDE--TTYERLAEETLDSLAEFFEDLADKPYTFEDYDVS

Mouse                         NPSSLDE--TAYERLAEETLDSLAEFFEDLADKPYTLEDYD

Rat                           NPSSLDE--TAYERLAEETLDALAEFFEDLADKPYTLKDYD

Bovine                        DAGTLDD--TTYERLAEETLDSLAEFFEDLADKPYTFEDYD

Caenorhabditis elegans        ---------NEYETAADSTLERLSDYFDQIADSFPVSEQFD

Drosophila                    TESTLDG--ATYERVCSDTLDALCDYFEELTENASELQGTD

Slime mold                    NNTKPISDVNLFHDIVDEEFELFVDRLEILSEA-NTCEGFE

Baker's yeast                 PQEVLNLPLEKYHEEADDYLDHLLDSLEELSEAHPDCIP-D

Fission yeast                 HNGALTD--LEYHRVADDTLDVLNDTFEDLLEEVGK-KDYD

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	42 – 210	Frataxin intermediate form
Chain	56 – 210	Frataxin(56-210)
Chain	78 – 210	Frataxin(78-210)
Chain	81 – 210	Frataxin mature form
Helix	92 – 114

Literature citations

Identification of a missense mutation in a Friedreich's ataxia patient: implications for diagnosis and carrier studies.
Bartolo C.; Mendell J.R.; Prior T.W.;
Am. J. Med. Genet. 79:396-399(1998)
Cited for: VARIANT FRDA SER-106;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q16595: Variant p.Leu106Ser